CRISPR-Modified Skin Grafts to Treat Addiction? ‘The Opportunities Are Endless,’ Says CEO

AddGraft Therapeutics has developed a novel platform that aims to effectively treat substance use disorders with genetically engineered skin grafts – a first-of-its-kind treatment with myriad applications. Developed by University…

Multifunctional Nanomedicine Developed Using Novel UChicago Tech Gets FDA Nod to Initiate Clinical Trials

Coordination Pharmaceuticals, Inc. (CPI) recently announced that the FDA has approved the company's Investigational New Drug (IND) application to initiate a first-in-human Phase 1 clinical study of its novel cancer…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept